tiprankstipranks
Trending News
More News >
Q32 Bio (QTTB)
NASDAQ:QTTB
US Market

Q32 Bio (QTTB) Income Statement

Compare
825 Followers

Q32 Bio Income Statement

Last quarter (Q4 2024), Q32 Bio's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Q32 Bio's net income was $-14.19M. See Q32 Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 1.16M$ 6.65M$ 33.97M$ 2.70M$ 1.67M
Gross Profit
$ 578.00K$ 4.05M$ 24.43M$ 2.70M$ 1.67M
Operating Expenses
$ 92.68M$ 45.88M$ 36.69M$ 124.06M$ 105.29M
Depreciation and Amortization
$ 578.00K$ 2.60M$ 9.54M$ 8.90M$ 6.32M
EBITDA
$ -86.50M$ -38.85M$ -86.22M$ -121.36M$ -103.63M
Operating Income
$ -92.10M$ -39.23M$ -36.69M$ -130.26M$ -109.94M
Other Income/Expenses
$ 5.02M$ -3.52M$ -324.00K$ 1.57M$ 6.03M
Pretax Income
$ -87.08M$ -42.75M$ -37.02M$ -128.69M$ -103.92M
Net Income
$ -112.96M$ -42.81M$ -37.56M$ -128.69M$ -103.92M
Per Share Metrics
Basic EPS
$ -4.51$ -13.42$ -12.23$ -50.46$ -44.41
Diluted EPS
$ -4.51$ -13.42$ -12.23$ -50.46$ -44.41
Weighted Average Shares Outstanding
11.93M 3.19M 3.07M 2.55M 2.34M
Weighted Average Shares Outstanding (Diluted)
11.93M 3.19M 3.07M 2.55M 2.34M
Currency in USD

Q32 Bio Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis